Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-19-002734
Filing Date
2019-08-22
Accepted
2019-08-21 19:13:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT 2 cns_s1a2.htm S-1/A 1134600
2 CONSENT cns_ex2301.htm EX-23.1 2778
3 GRAPHIC malonelogo.jpg GRAPHIC 6186
  Complete submission text file 0001683168-19-002734.txt   1147035
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-232443 | Film No.: 191044032
SIC: 2834 Pharmaceutical Preparations